TOP  

MANY THANKS TO JESSICA STEVENS FOR HER GENEROSITY IN SUPPLYING THIS INFORMATION

 ·  Back to previous page

  ·   Home

·   In The Beginning

·  Late-stage Infection

·   Symptoms

·   Additional Symptoms

·   Early Detection

·   Treatment

·   Co-infections

·  Testing

·   Jarisch-Herxheimer Reaction

·  In Conclusion 1

*Books*

·   The Politics of Lyme Disease

·   Antibiotics

·   The Bad News

·  Mechanism of Action

·   Survival Tactics

·   In Conclusion 2

·  International Lyme and Associated Diseases Society (ILADS)

Lyme Disease Basics: Part I and II by L. James Johnson Spotlight on Lyme

In The Beginning:  Although the first record of a condition associated with Lyme disease dates back to the 1880s, Lyme disease is named after the Connecticut town of Lyme where it was first recognized in the United States in 1977.  Lyme disease is a bacterial infection caused by a spirochete (spiral-shaped bacteria) called Borrelia burgdorferi (Bb). The bacterium is named after the person who discovered it, Dr. Willy Burgdorfer.

More than 100 strains of the bacterium that cause Lyme disease have been identified in the United States. 300 bacterial strains of the Bb organism have been identified throughout the world. Cases of Lyme disease have been reported in North and South America, Europe, Asia, Africa and Australia.   Both humans and animals can be infected with Lyme disease through the bite of an infected tick. In the United States Lyme infection is usually transmitted by, though not limited to, three species of tick:

·         The black-legged tick (ixodes scapularis) on the East Coast and in the Midwest (commonly known as the deer tick).

·         The western black-legged tick (ixodes pacificus) in the Western U.S. (also commonly known as the deer tick).

·         The lone star tick (amblyomma americanum), located within a rectangle encompassing Texas, Florida, Rhode Island, and Iowa. TOP

Late-stage Infection:  When Lyme disease goes undetected, undiagnosed and untreated for months or years following infection; the bacteria can spread to the nervous system, the heart and other organs, tendons and joints. This late-stage infection can result in a wide variety of physical, emotional, and mental or cognitive symptoms. The late-stage list of symptoms is long and can include arthritis, heart abnormalities, Bell's palsy (paralysis of one or both sides of the face) and severe cognitive or mental dysfunction including memory loss, confusion, psychiatric problems, etc.

Misdiagnosed: Lyme disease is often referred to as the Great Pretender because the symptoms of Lyme disease can so closely mimic the symptoms of other diseases. Although no one knows the exact figures, Lyme patients have been misdiagnosed with many other conditions including chronic fatigue syndrome, fibromyalgia, multiple sclerosis, menopause, depression, Alzheimer's disease, and Lou Gehrig's disease. Other patients have failed to receive any kind of definitive diagnosis long after the presentation of symptoms. TOP

Symptoms:  Early signs of Lyme disease include flu-like symptoms and a Lyme rash. The symptoms include muscle aches, joint pain, fatigue, fever and headache. Most symptoms show up days or weeks and occasionally months following infection.

The Lyme rash is referred to as Erythema migrans or EM. It used to be believed that only a bulls-eye rash at the site of the tick bite indicated Lyme disease. We now know this is not accurate. We know that the rash may not show up at all, or it may appear to light in color to be noticed. The rash can be shaped like a bulls-eye, it can be smooth or bumpy, it may or may not feel warm, and there can be multiple rashes that appear at the site of the tick bite or elsewhere on the body.

Once the infection becomes established, symptoms of Lyme disease vary but may include pain in muscles and joints, fatigue, swollen glands, fever, upset stomach, headache, forgetfulness, sleep disorders, depression, and sensitivity to light and sound, to name a few. TOP

Additional Symptoms Include:

Early Detection:  Virtually everyone involved with Lyme disease agrees that early detection and treatment of Lyme disease significantly improves the chance of a full recovery. Some experts describe a window of opportunity following infection when treating the disease with antibiotic therapy can result in a high cure rate and lessen the chance of chronic, long-term problems. Although not proven, some suggest that this window of opportunity lasts up to six to eight weeks.

Unfortunately, receiving a Lyme diagnosis followed by adequate treatment can be difficult. It has been reported that it takes an average of 22 months and seven doctors for the average Lyme patient to be diagnosed with a Bb infection. This follows the fact that many people infected with Lyme disease do not remember being bitten by a tick, which can further delay treatment. The inability to diagnose and treat Lyme disease in a timely fashion may be adding to the number of patients who suffer from chronic symptoms.  It is estimated that as many as 15 to 20 percent of Lyme patients suffer from persistent and chronic symptoms. TOP

Treatment:  Lyme disease is a bacterial infection and like other bacterial infections it is treated with antibiotics. Antibiotics are administered orally, with intramuscular (IM) injections, or intravenously (IV) through the veins. Combinations of these delivery methods are common. This multiple or "shotgun" approach to antibiotic therapy is used in hopes of affecting the Bb organism in as many ways as possible.

Lyme patients often ask, "Why am I affected by symptoms different from other Lyme patients?" Another question is, "Why won't an antibiotic that works for someone else work for me?" Just as no two Lyme patients appear to be affected by Lyme bacteria in the same way, a patient's response to antibiotic therapy is highly individual, too. We don't know exactly why this is so, however, there is speculation:

  1. Different strains of the bacteria react differently to each antibiotic.
  2. The duration of the infection can affect the response.
  3. So too can the amount of time between the onset of symptoms and treatment.
  4. Also, the location of the Bb organism in the body.
  5. Co-infections (see below). TOP

Testing:  The diagnosis of Lyme disease remains clinically based or based primarily on symptoms alone. This is because there is no common test available that can accurately rule out or confirm Lyme infection. Amazingly, the lack of a common test also means that medical science cannot precisely determine whether someone is cured of Lyme disease. This situation leads to contradictory treatment guidelines that are often more guesswork than many patients prefer, and less exact than many physicians and health insurance companies are comfortable with. TOP

Current testing for Lyme disease mainly includes testing for antibodies to the Bb organism. This results in partial guesswork where false positive results and false negative results are common. The ELISA and Western Blot tests are the most common antibody tests for Lyme disease. The Lyme Urine Antigen Test (LUAT) is a newer antibody test that is also being used by Lyme literate physicians.

A more accurate and somewhat more expensive test is the Polymerase Chain Reaction (PCR) test. It is designed to confirm that Lyme bacteria are present. A positive PCR test almost always guarantees that Lyme disease is present, depending on the accuracy of the lab performing the work. However, because it can be difficult to isolate the Bb organism's DNA, a negative PCR test does not eliminate a Lyme disease diagnosis. TOP

Lyme Disease Basics PT II:  Lyme disease is complicated and confusing. After all, if medical science can't agree on the diagnosis and treatment of Lyme disease then how can Lyme patients and their families understand this devastating illness? It is my hope that this article will help you understand the basics of one of the fastest growing

In the last issue of Spotlight on Lyme we looked at the following areas of concern as they relate to Lyme disease: 

Co-infections:  Co-infections can include more than one strain of the Bb organism and may include the tick-borne disorders of Babesiosis and/or              Ehrlichiosis. Babesiosis and Ehrlichiosis are also bacterial infections that present Lyme-like symptoms. However, treatment is often handled in a different   manner from Lyme disease. Information on co-infections is relatively new. For this reason all Lyme patients-new patients and those with established, long-term symptoms-need to request additional tests for Ehrlichiosis and Babesiosis if they have not already been performed. Unfortunately, there is no common test to determine which strain or strains of the Bb organism are present.

Jarisch-Herxheimer Reaction:  Without an accurate and common test for Lyme disease, the Jarisch-Herxheimer reaction is often used as a clinical diagnostic tool to help determine the presence of Lyme bacteria. A Herxheimer reaction occurs in Lyme patients after they begin antibiotic therapy. It is important to note that a Herxheimer reaction is not a common reaction that is associated with most other diseases or with other viral, bacterial or fungal infections. It is limited to a few specific bacterial infections such as syphilis and Lyme disease. Both are spirochetes and spiral-shaped bacteria.

A Herxheimer reaction occurs when symptoms recur or flare up. Some call it a healing crisis because the patient gets worse before they get better. A Herxheimer reaction usually occurs within days to weeks of starting antibiotic therapy. In simple terms, a Herxheimer reaction occurs when Lyme bacteria are killed off more quickly than the body's organs (kidneys and liver) are able to process them. This increases the number of toxins in the blood stream. The higher the toxin count, the more severe the symptoms the patient experiences.

Some health care professionals believe that a Herxheimer reaction can confirm that the Bb organism is present in the body by the fact that a bacteria die-off is causing the herx. If the die-off coincides with antibiotic use, it can confirm the effectiveness of the antibiotic. Thus, for the frontline physician, the Herxheimer reaction can assist in the clinical diagnosis by unofficially confirming the presence of the Bb organism.

In Conclusion 1:  This article just touches the surface of what we think we know about Lyme disease. In the next edition of Spotlight on Lyme, Part II of this two part series will focus on the use of antibiotics in fighting Lyme disease. We will look at how antibiotics work and why more than one antibiotic is usually needed for treatment. We will also look at the devastating survival tactics that the Bb organism uses to evade both antibiotics and our immune system.

Antibiotics:  Lyme disease is a bacterial infection caused by a spirochete (spiral-shaped bacteria) called Borrelia burgdorferi (Bb). Like other bacterial infections it is treated with antibiotics. Antibiotics are administered orally, with intramuscular (IM) injections, or intravenously (IV) through the veins.

Physicians not only prescribe more than one oral antibiotic at a time, but they combine oral antibiotics with IM or IV antibiotics. This shotgun or multiple approach to antibiotic therapy is used in hopes of affecting the Bb organism in as many ways as possible.

Just as no two Lyme patients appear to be affected by Lyme bacteria in the same way, a patient's response to antibiotic therapy is highly individual, too. The individual nature of an antibiotic's effect on a patient is believed to be due in part to the theory that different strains of the bacteria react differently to each antibiotic. Other factors may include the duration of infection, the amount of time between the onset of symptoms and treatment, and the location of the Bb organism in the body. Also, co-infections or the transmittal of more than one infectious disease can occur from a single tick bite. Co-infections may include more than one strain of the Lyme bacteria and may include the tick-borne disorders of Babesiosis and/or Ehrlichiosis. See Part I for more information on co-infections. TOP

The Politics of Lyme Disease:  One of the more perplexing questions about Lyme disease is why a three to six week course of antibiotics won't eliminate the disease for everyone. Before we speculate on how the bacteria evades the body's defenses we first have to look at the politics of Lyme disease to see why Lyme patients often have difficulty receiving adequate antibiotic treatment.

Some health care professionals are more tradition-bound and conservative in their approach to Lyme disease. They have adopted protocols for treating Lyme disease that don't go much beyond relatively short-term antibiotic therapy. This group believes that in almost all cases just one or two courses of oral antibiotics are all that are required to eradicate the bacteria. They believe that persistent, chronic Lyme symptoms are not the result of an ongoing infection in the body. They believe that what appears to be a Lyme infection is probably the result of a dysfunctional auto-immune system response or some other process occurring in the body.

Others-especially those physicians who remain on the frontline of the long-term treatment of Lyme patients-believe that Lyme bacteria are not always eliminated by short-term courses of antibiotics. They believe that this is especially true if the disease went undiagnosed and untreated for months or years following infection.

Further, this latter group believes that the Bb organism can persist through months and even years of antibiotic therapy, depending upon a wide range of individual factors relating to the patient and to the strain(s) of bacteria. The survival characteristics of the bacteria themselves play a crucial role in Lyme bacteria's persistent longevity.

Remember, it is believed that Lyme bacteria can shift to a dormant state by entering and residing in a human cell or by encapsulating itself in the body's protein. Some believe that this has the effect of neutralizing the body's defensive mechanism and the offensive mechanism employed by antibiotics.

If it is true that Lyme bacteria can evade antibiotics by shifting to a dormant mode it has serious consequences for the diagnosis and treatment of chronic, persistent symptoms. Specifically, this means that conservative treatment protocols, which call for short-term courses of antibiotics, may actually prolong some cases of Lyme infection. If chronic Lyme symptoms are the result of an active, late-stage Lyme infection, any delay in full and comprehensive antibiotic treatment may have devastating results for the Lyme patient. TOP

The Bad News:  Even though physicians can out-maneuver some of the Lyme bacterium's survival tactics-such as using combinations of antibiotics-there are those who believe that antibiotics alone cannot eliminate the Bb organism if it is in a dormant or sleeping state. Remember, it is believed that Lyme bacteria can shift to a dormant state by entering and residing in a human cell or by encapsulating itself in the body's protein. Some believe that this has the effect of neutralizing the body's defensive mechanism and the offensive mechanism employed by antibiotics.

Mechanism of Action:  Antibiotics and other anti-infective agents (anything that counteracts infections) can kill different kinds of bacteria. However, an antibiotic's mechanism of action-or how they kill bacteria-varies depending upon the type of antibiotic used. Because the mechanism of action varies among antibiotics, a specific antibiotic or combination of antibiotics may be a better choice than other combinations when treating Lyme disease.

For example, penicillins and cephalosporins circulate mainly in the body's fluids and are incapable of entering cells where the Bb organism can reside. This indicates that these classes of antibiotics may not be able to eradicate Lyme bacteria from the body, especially Lyme bacteria that reside in human cells or those that move away from blood blow and towards other parts of the body.

However, other classes of antibiotics, such as macrolides like Zithromax (azithromycin) are known to have higher tissue concentration levels when compared to the blood concentration levels it usually attains. Zithromax is also known to have an ability to penetrate some cells in our body more effectively than other antibiotics. This may counteract Lyme bacteria that have the ability to enter certain types of our cells. Thus, Zithromax is prescribed specifically to attack Lyme bacteria that may become established within the body's cells, along with killing Lyme bacteria residing outside the cells in deep tissue areas.

Survival Tactics:  There appears to be two major ways that Lyme bacteria evade the body's defenses and antibiotic therapy. First, research shows that Lyme bacteria can use the body's own protein to encapsulate it self. This is also described as the Lyme bacterium shifting to a dormant or sleeping state. The reason that the organism undergoes this change is not fully understood. Some believe that this is a survival tactic because it may not be possible for our immune system to destroy the bacterium when it is in this state. Also, antibiotics may have little or no effect on the Bb organism when it is encapsulated and dormant.

Second, research also shows that the Lyme bacterium appears to be able to enter certain types of human cells. This ability may also be considered a survival tactic because it results in the bacterium evading some or all antibiotics as well as the body's immune system.

However, the final piece of this puzzle has to be considered a genetic marvel no matter how devastating it is to Lyme patients. When Lyme bacteria have successfully survived attacks from our body's defenses and from antibiotics by shifting to a dormant or sleeping state, they shift back to an active state and resume reproduction and effectively re-seed the body with Lyme bacteria. This reestablishes the Lyme infection. If it is true that dormant bacteria can wake up and re-seed the body, this particularly devastating maneuver indicates that short-term courses of antibiotics may be ineffective in eradicating Lyme bacteria from the body.

In Conclusion 2:  Science in general and medical science in particular, prefers absolute and unmistakable testing, data and conclusions on which to base treatment guidelines. Lyme disease was not recognized in the United States until 1977. Scientific research is lagging and there is much we don't know. Based on current scientific knowledge, the diagnosis and treatment of Lyme disease cannot be absolute and certain. Instead-and no matter how unsettling this may be-until research catches up, the treatment of Lyme disease cannot be anything but subjective, open to question, individualized, and often complex.

Medical science will continue to be perplexed and divided about Lyme disease until proper testing options become available. This has serious consequences for Lyme patients who are often left to fend for themselves in a confusing and contradictory medical environment. In an ideal world, people who are in various stages of illness - many of whom have been incapacitated by their Lyme symptoms -should not be put in this situation by a medical system whose purpose is to help, not frustrate their recovery. Being open-minded is a start.   TOP

 

Updated 4/15/06

Basic Information about Lyme Disease

The International Lyme and Associated Diseases Society (ILADS)

  1. Lyme disease is transmitted by the bite of a tick, and the disease is prevalent across the United States and throughout the world. Ticks know no borders and respect no boundaries. A patient's county of residence does not accurately reflect his or her Lyme disease risk because people travel, pets travel, and ticks travel. This creates a dynamic situation with many opportunities for exposure to Lyme disease for each individual.
  2. Lyme disease is a clinical diagnosis. The disease is caused by a spiral-shaped bacteria (spirochete) called Borrelia burgdorferi. The Lyme spirochete can cause infection of multiple organs and produce a wide range of symptoms. Case reports in the medical literature document the protean manifestations of Lyme disease, and familiarity with its varied presentations is key to recognizing disseminated disease..
  3. Fewer than 50% of patients with Lyme disease recall a tick bite. In some studies this number is as low as 15% in culture-proven infection with the Lyme spirochete.
  4. Fewer than 50% of patients with Lyme disease recall any rash. Although the erythema migrans (EM) or “bull’s-eye” rash is considered classic, it is not the most common dermatologic manifestation of early-localized Lyme infection. Atypical forms of this rash are seen far more commonly. It is important to know that the EM rash is pathognomonic of Lyme disease and requires no further verification prior to starting an appropriate course of antibiotic therapy.
  5. The Centers for Disease Control and Prevention (CDC) surveillance criteria for Lyme disease were devised to track a narrow band of cases for epidemiologic purposes. As stated on the CDC website, the surveillance criteria were never intended to be used as diagnostic criteria, nor were they meant to define the entire scope of Lyme disease.
  6. The ELISA screening test is unreliable. The test misses 35% of culture proven Lyme disease (only 65% sensitivity) and is unacceptable as the first step of a two-step screening protocol. By definition, a screening test should have at least 95% sensitivity.
  7. Of patients with acute culture-proven Lyme disease, 20–30% remain seronegative on serial Western Blot sampling. Antibody titers also appear to decline over time; thus while the Western Blot may remain positive for months, it may not always be sensitive enough to detect chronic infection with the Lyme spirochete. For “epidemiological purposes” the CDC eliminated from the Western Blot analysis the reading of bands 31 and 34. These bands are so specific to Borrelia burgdorferi that they were chosen for vaccine development. Since a vaccine for Lyme disease is currently unavailable, however, a positive 31 or 34 band is highly indicative of Borrelia burgdorferi exposure. Yet these bands are not reported in commercial Lyme tests.
  8. When used as part of a diagnostic evaluation for Lyme disease, the Western Blot should be performed by a laboratory that reads and reports all of the bands related to Borrelia burgdorferi. Laboratories that use FDA approved kits (for instance, the Mardx Marblot®) are restricted from reporting all of the bands, as they must abide by the rules of the manufacturer. These rules are set up in accordance with the CDCs surveillance criteria and increase the risk of false-negative results. The commercial kits may be useful for surveillance purposes, but they offer too little information to be useful in patient management.
  9. There are 5 subspecies of Borrelia burgdorferi, over 100 strains in the US, and 300 strains worldwide. This diversity is thought to contribute to the antigenic variability of the spirochete and its ability to evade the immune system and antibiotic therapy, leading to chronic infection.
  10. Testing for Babesia, Anaplasma, Ehrlichia and Bartonella (other tick-transmitted organisms) should be performed. The presence of co-infection with these organisms points to probable infection with the Lyme spirochete as well. If these coinfections are left untreated, their continued presence increases morbidity and prevents successful treatment of Lyme disease.
  11. A preponderance of evidence indicates that active ongoing spirochetal infection with or without other tick-borne coinfections is the cause of the persistent symptoms in chronic Lyme disease.
  12. There has never been a study demonstrating that 30 days of antibiotic treatment cures chronic Lyme disease. However there is a plethora of documentation in the US and European medical literature demonstrating by histology and culture techniques that short courses of antibiotic treatment fail to eradicate the Lyme spirochete. Short treatment courses have resulted in upwards of a 40% relapse rate, especially if treatment is delayed.
  13. Most cases of chronic Lyme disease require an extended course of antibiotic therapy to achieve symptomatic relief. The return of symptoms and evidence of the continued presence of Borrelia burgdorferi indicates the need for further treatment. The very real consequences of untreated chronic persistent Lyme infection far outweigh the potential consequences of long-term antibiotic therapy.
  14. Many patients with chronic Lyme disease require treatment for 1–4 years, or until the patient is symptom-free. Relapses occur and maintenance antibiotics may be required. There are no tests currently available to prove that the organism is eradicated or that the patient with chronic Lyme disease is cured. Like syphilis in the 19th century, Lyme disease has been called the great imitator and should be considered in the differential diagnosis of rheumatologic and neurological conditions, as well as chronic fatigue syndrome, Fibromyalgia, somatization disorder and any difficult-to-diagnose multi-system illness.
  15. Like syphilis in the 19th century, Lyme disease has been called the great imitator and should be considered in the differential diagnosis of rheumatologic and neurological conditions, as well as chronic fatigue syndrome, Fibromyalgia, somatization disorder and any difficult-to-diagnose multi-system illness. TOP